Fund Holdings — SECTORAL ASSET MANAGEMENT INC

Total Portfolio Value:
$143.30M
Total Bought:
$42.17M
Total Sold:
$27.68M
Net Transaction:
+$14.48M
Notable People:
Jerome Georges Pfund
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CONTINEUM THERAPEUTICS727,587727,5870$9.50M$11.93M8.32%+$2.42M
SHOULDER INNOVATIONS430,407430,4070$6.25M$8.73M6.09%+$2.47M
Eli Lilly and Company(LLY)6,3546,3540$5.84M$7.62M5.32%+$1.78M
UnitedHealth Group Incorporated(UNH)14,95713,235-1,722$4.05M$5.50M3.84%+$1.45M
Johnson & Johnson(JNJ)18,21818,2180$4.45M$4.63M3.23%+$173.6K
Oruka Therapeutics, Inc.(ORKA)041,987+41,987$0$4.00M2.79%+$4.00M
BioNTech SE(BNTX)22,16441,869+19,705$2.05M$3.90M2.72%+$1.85M
Definium Therapeutics, Inc.(DFTX)078,310+78,310$0$3.68M2.57%+$3.68M
DexCom, Inc.(DXCM)23,23150,756+27,525$1.46M$3.42M2.39%+$1.96M
Arcus Biosciences, Inc.(RCUS)45,070110,870+65,800$1.04M$3.42M2.39%+$2.38M
Amgen Inc.(AMGN)9,2109,2100$3.51M$3.34M2.33%-$179.9K
Summit Therapeutics Inc.(SMMT)69,615220,180+150,565$1.40M$3.21M2.24%+$1.81M
iRhythm Holdings, Inc.(IRTC)026,070+26,070$0$3.10M2.16%+$3.10M
AbbVie Inc.(ABBV)12,20012,2000$2.65M$3.07M2.14%+$416.6K
Merck & Co., Inc.(MRK)21,48021,4800$2.58M$2.77M1.94%+$189.2K
ARRIVENT BIOPHARMA30,01379,043+49,030$720.4K$2.75M1.92%+$2.03M
Vertex Pharmaceuticals Incorporated(VRTX)7,0075,432-1,575$3.46M$2.70M1.88%-$758.9K
argenx SE(ARGX)3,5642,831-733$2.74M$2.63M1.83%-$110.5K
Gilead Sciences, Inc.(GILD)27,49020,620-6,870$4.13M$2.61M1.82%-$1.53M
Insmed Incorporated(INSM)19,66823,216+3,548$3.38M$2.48M1.73%-$905.5K
TECTONIC THERAPEUTIC19,05971,009+51,950$628.2K$2.44M1.70%+$1.81M
INTUITIVE SURGIC INC5,2505,850+600$2.42M$2.33M1.62%-$93.8K
Immatics N.V.(IMTX)66,830224,928+158,098$692.7K$2.28M1.59%+$1.59M
Stryker Corporation(SYK)5,8747,129+1,255$1.93M$2.25M1.57%+$318.8K
AVALO THERAPEUTICS INC0119,923+119,923$0$2.22M1.55%+$2.22M
CRESCENT BIOPHARMA INC.0121,300+121,300$0$2.18M1.52%+$2.18M
Roivant Sciences Ltd.(ROIV)32,50061,100+28,600$1.02M$2.16M1.51%+$1.15M
IQVIA Holdings Inc.(IQV)8,30710,848+2,541$1.42M$2.10M1.46%+$679.4K
Pulse Biosciences, Inc.(PLSE)067,895+67,895$0$1.88M1.31%+$1.88M
Danaher Corporation(DHR)9,5979,5970$1.82M$1.83M1.28%+$11.1K
Thermo Fisher Scientific Inc.(TMO)3,5083,5080$1.72M$1.76M1.23%+$35.6K
ABBOTT LABS25,57818,080-7,498$2.63M$1.64M1.14%-$985.5K
Alphatec Holdings, Inc.(ATEC)0185,900+185,900$0$1.61M1.12%+$1.61M
Boston Scientific Corporation(BSX)34,78036,330+1,550$2.18M$1.55M1.08%-$631.9K
TransMedics Group, Inc.(TMDX)021,950+21,950$0$1.46M1.02%+$1.46M
Cytokinetics, Incorporated(CYTK)7,30016,330+9,030$544.6K$1.39M0.97%+$846.5K
Regeneron Pharmaceuticals, Inc.(REGN)2,9192,169-750$2.48M$1.35M0.94%-$1.13M
CVS Health Corporation(CVS)013,000+13,000$0$1.34M0.94%+$1.34M
EDWARDS LIFESCIENCES17,33814,826-2,512$1.39M$1.34M0.94%-$47.3K
Trevi Therapeutics, Inc.(TRVI)74,44665,596-8,850$939.5K$1.22M0.85%+$283.9K
Bristol-Myers Squibb Company(BMY)21,15021,1500$1.28M$1.22M0.85%-$64.1K
Vera Therapeutics, Inc.(VERA)25,57325,5730$1.08M$1.10M0.77%+$12.7K
Cogent Biosciences, Inc.(COGT)22,14026,740+4,600$902.4K$1.03M0.72%+$132.4K
Medtronic plc(MDT)11,10011,1000$961.8K$876.3K0.61%-$85.5K
Tarsus Pharmaceuticals, Inc.(TARS)11,27213,285+2,013$852.5K$836.2K0.58%-$16.3K
Kura Oncology, Inc.(KURA)71,48071,4800$606.0K$784.1K0.55%+$178.1K
Centene Corporation(CNC)012,000+12,000$0$770.3K0.54%+$770.3K
United Therapeutics Corporation(UTHR)1,7101,370-340$1.15M$742.3K0.52%-$403.3K
Hinge Health, Inc.(HNGE)12,2448,744-3,500$472.1K$725.8K0.51%+$253.6K
Nektar Therapeutics(NKTR)10,85110,111-740$820.7K$705.8K0.49%-$114.8K
Alnylam Pharmaceuticals, Inc.(ALNY)2,3102,3100$864.2K$695.4K0.49%-$168.9K
Ascendis Pharma A/S(ASND)02,570+2,570$0$685.5K0.48%+$685.5K
Pfizer Inc.(PFE)27,50027,5000$772.2K$662.2K0.46%-$110.0K
ARDELYX INC122,394122,3940$781.1K$624.2K0.44%-$156.9K
Privia Health Group, Inc.(PRVA)27,13624,136-3,000$558.2K$621.0K0.43%+$62.8K
PTC Therapeutics, Inc.(PTCT)6,6507,470+820$515.1K$609.3K0.43%+$94.3K
Ionis Pharmaceuticals, Inc.(IONS)7,2007,2000$617.2K$570.9K0.40%-$46.4K
AGOMAB THERAPEUTICS43,50043,5000$477.3K$564.6K0.39%+$87.3K
BioMarin Pharmaceutical Inc.(BMRN)9,4509,4500$607.3K$540.7K0.38%-$66.5K
BeOne Medicines AG(ONC)1,8701,8700$631.1K$532.9K0.37%-$98.2K
Humana Inc.(HUM)01,250+1,250$0$497.3K0.35%+$497.3K
Jazz Pharmaceuticals plc(JAZZ)1,7501,7500$371.3K$421.7K0.29%+$50.4K
Royalty Pharma plc(RPRX)7,2007,2000$393.8K$403.7K0.28%+$9.9K
Biogen Inc.(BIIB)1,8501,8500$385.9K$399.7K0.28%+$13.8K
Mineralys Therapeutics, Inc.(MLYS)31,61814,565-17,053$895.1K$393.0K0.27%-$502.2K
Illumina, Inc.(ILMN)2,1322,1320$296.1K$374.9K0.26%+$78.8K
Axsome Therapeutics, Inc.(AXSM)1,5001,5000$289.9K$367.2K0.26%+$77.3K
Syndax Pharmaceuticals, Inc.(SNDX)31,68015,680-16,000$787.5K$342.8K0.24%-$444.7K
Revolution Medicines, Inc.(RVMD)1,8301,8300$202.3K$342.7K0.24%+$140.4K
ABIVAX Société Anonyme(ABVX)2,3402,3400$297.9K$311.8K0.22%+$14.0K
BridgeBio Pharma, Inc.(BBIO)8,1004,100-4,000$687.3K$305.4K0.21%-$381.9K
Moderna, Inc.(MRNA)4,3504,3500$247.9K$304.6K0.21%+$56.7K
Guardant Health, Inc.(GH)1,9801,9800$205.5K$297.1K0.21%+$91.5K
Incyte Corporation(INCY)2,3502,3500$254.1K$266.4K0.19%+$12.3K
ORIC Pharmaceuticals, Inc.(ORIC)23,50023,5000$332.7K$254.5K0.18%-$78.1K
ARS PHARMACEUTICALS79,15029,900-49,250$676.7K$239.5K0.17%-$437.2K
STRUCTURE THERAPEUTICS14,1024,325-9,777$710.8K$232.1K0.16%-$478.7K
Medpace Holdings, Inc.(MEDP)4304300$228.1K$227.7K0.16%-$366
Tempus AI, Inc.(TEM)03,880+3,880$0$224.8K0.16%+$224.8K
ORBUS PHARMACEUTICALS HLDGS020,000+20,000$0$187.6K0.13%+$187.6K
PALISADE BIO INC88,00088,0000$172.4K$183.9K0.13%+$11.5K
ENGENE THERAPEUTICS INC021,700+21,700$0$37.5K0.03%+$37.5K
Alignment Healthcare, Inc.(ALHC)26,9110-26,911$474.2K$0—-$474.2K
Ascendis Pharma A/S(ASND)2,8000-2,800$728.3K$0—-$728.3K
BOUNDLESS BIO678,5740-678,574$746.4K$0—-$746.4K
EVOMMUNE INC589,0050-589,005$13.54M$0—-$13.54M
Inspire Medical Systems, Inc.(INSP)7,2250-7,225$372.7K$0—-$372.7K
Neurocrine Biosciences, Inc.(NBIX)2,3000-2,300$343.8K$0—-$343.8K
Omada Health, Inc.(OMDA)25,6200-25,620$322.0K$0—-$322.0K
RadNet, Inc.(RDNT)7,9990-7,999$447.1K$0—-$447.1K
Rapport Therapeutics, Inc.(RAPP)25,4210-25,421$835.0K$0—-$835.0K
uniQure N.V.(QURE)29,2450-29,245$499.4K$0—-$499.4K
Page 1 of 1
SECTORAL ASSET MANAGEMENT INC — 13F Holdings — Q2 2026 | TickerTrail